From Wikipedia, the free encyclopedia
| This article must adhere to the policy on biographies of living persons. Controversial material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libellous. If such material is repeatedly inserted or if there are other concerns relative to this policy, report it on the living persons biographies noticeboard. |
I removed the following material which I could not verify:
- Rorvik and five scientists received a provisional patent in 2006 for the use of phycocyanobilins in a number of disease processes and formed a company for the development of these substances.
AxelBoldt (talk) 22:49, 28 February 2008 (UTC)